The firm is a North America-based venture philanthropy investor affiliated with a private foundation dedicated to advancing research and innovation in brain tumors. The firm typically invests from Seed through Series A, with initial investments ranging from $250K–$2M and the potential for follow-on participation. The firm generally seeks to make several new investments annually and prefers to participate alongside other investors rather than lead financing rounds. The firm primarily targets companies located in the United States and Canada.
The firm focuses on technologies addressing brain tumors and related neurological conditions, including therapeutics, medical devices, diagnostics, software, and other healthcare innovations. The firm is open to a broad range of modalities and technologies, provided there is a clear or potential application in brain cancer. The firm may also consider companies initially developing technologies for other indications when the underlying approach could eventually be applied to brain tumors. For therapeutics, the firm generally prefers preclinical and early clinical-stage programs, while diagnostic technologies may be considered at later stages of clinical development.
From a company and management team perspective, the firm seeks founding teams with complementary scientific, technical, and commercial capabilities. Experience in business development, fundraising, or company building is viewed favorably but is not a strict requirement. The firm takes an active approach to supporting portfolio companies and can provide access to specialized scientific expertise, clinical research relationships, and a network of researchers and healthcare professionals.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
